OmniAb (OABI) Cash & Equivalents (2021 - 2026)

OmniAb (OABI) reported Cash & Equivalents of $22.9 million for Q1 2026, up 110.62% year-over-year from $10.9 million in Q1 2025, and up 14.25% quarter-over-quarter from $20.1 million in Q4 2025.

OmniAb (OABI) Cash & Equivalents (2021 - 2026) Analysis & Trends

OmniAb (OABI) has 6 years of Cash & Equivalents data on file, last reported at $22.9 million in Q1 2026.

  • Cash & Equivalents for Q1 2026 came in at $22.9 million, up 110.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.9 million (up 110.62% YoY), and the FY2025 annual result was $20.1 million, up 13.99% from the prior year.
  • Cash & Equivalents improved to $22.9 million in Q1 2026 per OABI's latest filing, from $20.1 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $33.4 million in Q4 2022 and troughed at $19847.0 in Q3 2022.
  • A 5-year average of $17.7 million and a median of $20.1 million in 2025 frame the typical range for Cash & Equivalents.
  • The sharpest annual moves came in 2022 and 2023: Cash & Equivalents plunged 94.52% in 2022, then jumped 106943.89% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $33.4 million in 2022, then slumped by 51.01% to $16.4 million in 2023, then climbed by 7.69% to $17.6 million in 2024, then advanced by 13.99% to $20.1 million in 2025, then advanced by 14.25% to $22.9 million in 2026.
  • Business Quant data shows OABI's Cash & Equivalents at $22.9 million in Q1 2026, $20.1 million in Q4 2025, and $28.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn 22.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.94 Mn
Dec 31, 2025 20.08 Mn
Sep 30, 2025 28.54 Mn
Jun 30, 2025 18.28 Mn
Mar 31, 2025 10.89 Mn
Dec 31, 2024 17.62 Mn
Sep 30, 2024 27.24 Mn
Jun 30, 2024 20.79 Mn
Mar 31, 2024 19.06 Mn
Dec 31, 2023 16.36 Mn
Sep 30, 2023 21.25 Mn
Jun 30, 2023 20.99 Mn
Mar 31, 2023 22.91 Mn
Dec 31, 2022 33.39 Mn
Sep 30, 2022 19,847.00
Jun 30, 2022 159,194.00
Mar 31, 2022 434,629.00
Sep 30, 2021 362,203.00
Jun 30, 2021 36,145.00